Figures & data
Figure 1. Reorganization of oncology services during the COVID-19 pandemic.
OncoImmunology
Volume 9, 2020 - Issue 1
Editorial
COVID-19: a challenge for oncology services
, , 
&
Laurence Zitvogelc Gustave Roussy Cancer Campus (GRCC), Villejuif, France;d Institut National de la Santé et de la Recherche Médicale (INSERM) U1015, Équipe Labellisée—Ligue Nationale Contre le Cancer, Villejuif, France;e Department of Medical Oncology, Gustave Roussy Cancer Campus (GRCC), Villejuif, France;f Center of Clinical Investigations in Biotherapies of Cancer (CICBT) 1428, Villejuif, France;g Faculté de Médecine Kremlin-Bicêtre, Université Paris Sud, Université Paris Saclay, France;h Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, Chinahttps://orcid.org/0000-0003-1596-0998
https://orcid.org/0000-0003-1596-0998 & Guido Kroemerh Suzhou Institute for Systems Medicine, Chinese Academy of Medical Sciences, Suzhou, China;i Cell Biology and Metabolomics Platforms, Gustave Roussy Cancer Campus, Villejuif, France;j Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM U1138, Centre de Recherche des Cordeliers, Paris, France;k Aix-Marseille Université, MEPHI, IRD, IHU Méditerranée Infection, Marseille, France;l Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France;m Karolinska Institute, Department of Women’s and Children’s Health, Karolinska University Hospital, Stockholm, Swedenhttps://orcid.org/0000-0002-9334-4405
https://orcid.org/0000-0002-9334-4405